Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNMT3B | Q9UBC3 | 12/20 | 1.00 |
| ▸ | DNMT1 | P26358 | 12/20 | 1.00 |
| ▸ | DOT1L | Q8TEK3 | 5/20 | 0.63 |
| ▸ | NT5E | P21589 | 1/20 | 0.58 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.57 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.57 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.57 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5052474 | 1.00 | DNMT3B (1.00) | DNMT3BDNMT1DOT1LNT5EPRMT1 | |
| SCHEMBL30225680 | 1.00 | DNMT3B (1.00) | DNMT3BDNMT1DOT1LNT5EPRMT1 | |
| SCHEMBL30225642 | 0.89 | DNMT3B (1.00) | DNMT3BDNMT1DOT1LPRMT1 | |
| SCHEMBL17309766 | 0.89 | DNMT3B (1.00) | DNMT3BDNMT1DOT1LPRMT1 | |
| SCHEMBL5062461 | 0.89 | DNMT3B (0.79) | DNMT3BDNMT1DOT1LNT5EPRMT1 | |
| SCHEMBL5055207 | 0.85 | DNMT3B (1.00) | DNMT3BDNMT1DOT1LPRMT1 | |
| SCHEMBL30225688 | 0.85 | DNMT3B (1.00) | DNMT3BDNMT1DOT1LPRMT1 | |
| SCHEMBL14174643 | 0.85 | DNMT3B (1.00) | DNMT3BDNMT1DOT1LPRMT1 | |
| SCHEMBL17309760 | 0.85 | DNMT3B (1.00) | DNMT3BDNMT1DOT1LPRMT1 | |
| SCHEMBL5062568 | 0.84 | ADORA1 (0.80) | DNMT3BDNMT1NT5EADORA3ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2952182-B1 | Compounds and methods for increasing the immune response to papillomavirus | UNIV HEIDELBERG (DE) | 2022-11-23 | — | — | EP | claimed |
| WO-2015185611-A1 | COMPOUNDS AND METHODS FOR INCREASING THE IMMUNE RESPONSE TO PAPILLOMAVIRUS | UNIVERSITÄTSKLINIKUM HEIDELBERG (DE) | 2015-12-10 | — | — | WO | claimed |
| EP-2952182-A1 | Compounds and methods for increasing the immune response to papillomavirus | Universitätsklinikum Heidelberg (DE) | 2015-12-09 | — | — | EP | claimed |
| US-20250161351-A1 | CANCER TREATMENT BY ARSENIC TRIOXIDE COMBINATION THERAPY | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2025-05-22 | — | — | US | disclosed |
| EP-4536250-A1 | CANCER TREATMENT BY ARSENIC TRIOXIDE COMBINATION THERAPY | Deutsches Krebsforschungszentrum (DE) | 2025-04-16 | — | — | EP | disclosed |
| WO-2023237710-A1 | CANCER TREATMENT BY ARSENIC TRIOXIDE COMBINATION THERAPY | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2023-12-14 | — | — | WO | disclosed |
| EP-2952182-B1 | Compounds and methods for increasing the immune response to papillomavirus | UNIV HEIDELBERG (DE) | 2022-11-23 | — | — | EP | disclosed |
| WO-2015185611-A1 | COMPOUNDS AND METHODS FOR INCREASING THE IMMUNE RESPONSE TO PAPILLOMAVIRUS | UNIVERSITÄTSKLINIKUM HEIDELBERG (DE) | 2015-12-10 | — | — | WO | disclosed |
| EP-2952182-A1 | Compounds and methods for increasing the immune response to papillomavirus | Universitätsklinikum Heidelberg (DE) | 2015-12-09 | — | — | EP | disclosed |